Use access key #2 to skip to page content.
$20.48 -6.76 (-24.82%)
8/27/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar jack0071 (71.06) Submitted: 9/15/06 7:23 AM : Outperform Start Price: $45.87 AMLN Score: -52.48

"Miracle" drugs for diabetics. Sales increasing for the forseeable future. Deep pipeline. Super management.

Report this Post Replies: 0 | Reply

Featured Broker Partners